Andere talen Glenmark Life Sciences Limited Bombay S.E.

Aandelen

GLS

INE03Q201024

Beurs gesloten - Bombay S.E. Andere beurzen 12:00:48 02-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
841,2 ^INR	+1,46%		+1,68%	+28,02%

25/04	Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024
25/04	Glenmark Life Sciences Limited rapporteert winstresultaten voor het vierde kwartaal eindigend op 31 maart 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Glenmark Life Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	25/04
Glenmark Life Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024	25/04
Glenmark Life Sciences Limited Announces Resignation of Gita Nayyar as Non-Executive, Independent Director	22/04
Nirma Limited completed the acquisition of 75% stake in Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited.	12/03
Glenmark Life Sciences Limited Announces Board Resignations, Effective March 6, 2024	06/03
Nirma Limited completed the acquisition of 0.000738% stake in Glenmark Life Sciences Limited.	29/02
Glenmark Pharmaceuticals Ltd. reports Consolidated Revenue of Rs. 29,096 Mn for Q3 FY 2023 24	15/02
India's Glenmark Pharma posts loss for Q3 as remediation cost weighs	14/02
India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO	23/01
Glenmark Life Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	23/01
Paracetamol maker Granules India posts marginal rise in Q3 profit	23/01
Glenmark Life Signs Master Supply Agreement with Japanese Drugmaker for Urinary Anti-Spasmodic API	19/01
Glenmark Life Sciences Announces Another CDMO Deal	19/01
India's Glenmark Pharma posts Q2 loss on exceptional legal costs	10/11
Paracetamol maker Granules India's Q2 revenue rises on higher N.America demand	09/11
India's Glenmark Life Sciences posts Q2 profit rise on API boost	20-10-23
Glenmark Life Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	20-10-23
Glenmark Life Sciences Limited Declares Interim Equity Dividend for the Financial Year 2023-24, Payable on or After October 23, 2023	09-10-23
Indian paracetamol maker Valiant Laboratories lists at 16% premium	06-10-23
Fitch Affirms Glenmark Pharmaceuticals at 'BB'; Outlook Stable	04-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Glenmark Life Sciences Limited Bombay S.E.

Aandelen

GLS

INE03Q201024

Andere talen

Filters